Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Renovaro Inc
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Announces Strategic Restructuring and Leadership Transition
October 16, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
September 19, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
September 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
September 13, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
September 11, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
May 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
April 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
April 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.